Cencora Inc. share price logo

Cencora Inc. Share Price

NYSE: COR

Large Cap

$327.54

+5.17

(+1.60%)

as on

Cencora Inc. Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $317.65
    $323.66
    downward going graph

    3.02%

    Downside

    -1.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $271.00
    $377.54
    downward going graph

    17.26%

    Downside

    15.27%

    Upside

    downward going graph

Cencora Inc. share price movements today

Previous Close
$322.37
Open
$317.84
Volume
1.1M
Day's Low - High
$317.65 - $323.66
52 Week Low - High
$271.00 - $377.54

Cencora Inc. Historical Returns

1 Month Return
+ 0.73 %
3 Month Return
-7.69 %
1 Year Return
+ 14.24 %
3 Year Return
0 %
5 Year Return
+ 163.44 %

Cencora Inc. Stock Fundamentals & Key Indicators

Check Cencora Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$63.7B

EPS (TTM)

17.621

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.15%

PE Ratio (TTM)

39.37

Industry PE ratio

27.713333333333335

PEG Ratio

0.7644

EBITDA

5.0B

Revenue (TTM)

325.8B

Profit Margin

0.50%

Return On Equity TTM

133.47%

Cencora Inc. Stock Valuation

Track how Cencora Inc. P/E has moved over time to understand its valuation trends.

Cencora Inc. in the last 5 years

  • Overview

  • Trends

Lowest (14.26x)

June 30, 2021

Industry (27.71x)

April 18, 2026

Today (39.37x)

April 18, 2026

Highest (20.98x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 39.37x

Cencora Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cencora Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$63.7B163.44%39.370.50%
HOLD$50.4B249.03%30.660.68%
BUY$107.1B348.48%25.061.09%
HOLD$8.9B10.76%23.613.02%

Stock Returns calculator for Cencora Inc. Stock including INR - Dollar returns

The Cencora Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 5Y

  • 7Y

  • 10Y

Cencora Inc. investment value today

Current value as on today

₹1,23,744

Returns

₹23,744

(+23.74%)

Returns from Cencora Inc. Stock

₹14,229 (+14.23%)

Dollar Impact

₹9,515 (+9.52%)

Analyst Recommendation on Cencora Inc. Stock

Based on 22 analysts

BUY

68.18%

Buy

31.82%

Hold

0.00%

Sell

Based on 22 analysts, 68.18% of analysts recommend a 'BUY' rating for Cencora Inc.. Average target price of $402.92

Cencora Inc. Share Price Target

Get share price movements and forecasts by analysts on Cencora Inc..

What analysts predicted

18.71%UPSIDE

Target Price

$402.92

Current Price

$327.54

Analyzed by

22 Analysts

Target

$402.92

Cencora Inc. target price $402.92, a slight upside of 18.71% compared to current price of $327.54. According to 22 analysts rating.

Cencora Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
68,922
72,252
68,414
74,241
79,050
81,487
75,453
80,663
83,728
85,932
Gross Profit
1,906
2,149
2,257
2,086
2,163
2,263
2,615
2,658
2,603
2,811
Operating Income
512
751
868
703
672
791
1,015
985
854
1,016
EBITDA
796
1,118
821
966
457
961
1,322
1,269
183
1,041
Interest Expense
74
58
76
58
54
61
132
116
109
93
Depreciation
276
278
279
280
279
281
263
258
263
264
Income Before Tax
446
783
467
628
125
620
928
896
-187
708
Income Tax Expense
97
180
45
140
117
126
211
206
146
142
Net Income
350
601
420
483
3
488
717
687
-339
559
Net Profit Margin
0.51%
0.83%
0.62%
0.65%
0.00%
0.60%
0.95%
0.85%
-0.41%
0.65%

Cencora Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Sep 2020
Dec 2020
Sep 2021
Dec 2021
Sep 2022
Dec 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
572
189,893
606
213,988
213,988
238,587
238,587
262,173
293,958
321,332
Gross Profit
-
4,791
-
6,269
-
7,600
-
7,756
8,701
10,141
Operating Income
-
2,024
-
2,675
-
2,751
-
2,446
3,040
3,647
EBITDA
-
-4,733
-
2,909
-
3,112
-
3,408
3,364
3,736
Interest Expense
-
158
-
182
-
231
-
275
248
419
Depreciation
-
391
-
514
-
693
-
963
1,118
1,068
Income Before Tax
-
-5,293
-
2,221
-
2,183
-
2,160
2,003
2,258
Income Tax Expense
-
-1,894
-
677
-
516
-
428
484
690
Net Income
75
-3,399
79
1,539
1,539
1,698
1,698
1,745
1,509
1,554
Net Profit Margin
13.24%
-1.79%
13.07%
0.72%
0.72%
0.71%
0.71%
0.67%
0.51%
0.48%

Cencora Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
603
420
487
88
488
717
689
-339
566
Operating Cash Flow
885
-878
2,477
1,000
-2,718
3,351
109
3,133
-2,305
Investing Cash Flow
-65
-166
-143
-241
-343
-4,077
-234
-321
-299
Financing Cash Flow
-551
323
-1,145
-957
3,209
-491
215
-683
43
Change in Cash
283
-751
1,190
-178
97
-1,216
96
2,080
-2,585

Cencora Inc. Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
414
1,615
854
-3,399
1,544
1,666
1,732
1,519
1,567
Operating Cash Flow
1,489
1,411
2,344
2,207
2,666
2,703
3,911
3,484
3,875
Investing Cash Flow
-498
-1,111
-375
-379
-6,141
-368
-2,602
-618
-4,977
Financing Cash Flow
-1,312
-242
-1,086
-603
1,952
-1,752
-2,222
-2,330
2,249
Change in Cash
-321
57
881
1,223
-1,527
523
-840
544
1,096

Mutual Funds that own Cencora Inc. Stock

Check out the Mutual Funds with significant holdings in Cencora Inc..

Global Institutional Holdings in Cencora Inc.

Funds
Holdings
The Goldman Sachs Group Inc
1.09%
Viking Global Investors LP
1.07%
Boston Partners Global Investors, Inc
2.32%
Geode Capital Management, LLC
2.81%
UBS Asset Mgmt Americas Inc
0.76%

Cencora Inc. News & Key Events

  • img

    Today's Timeline - 18 February

    Wed, 06:34 PM

    -

    Cencora to merge MWI Animal Health with Covetrus for $3.5 billion, retaining a 34.3% stake in the combined entity.

Insights on Cencora Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Cencora Inc has shown positive growth in its revenue over the last four quarters, increasing from $75.45 billion to $85.93 billion. This represents an average revenue increase of 4.2% each quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Cencora Inc has shown a positive trend in its profit over the last two quarters. The company's net profit increased from -339.70 million dollars to 559.64 million dollars. This represents an average growth of 160.7% in profit each quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Cardinal Health, Inc. has given 58.9% return, outperforming this stock by 44.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, COR stock has moved down by -1.3%

About Cencora Inc.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
OrganisationCencora Inc.
Headquarters1 West First Avenue, Conshohocken, PA, United States, 19428-1800
IndustryMedical Distribution
CEODr. Robert P. Mauch Ph.D., PharmD
E-voting on sharesClick here to vote

Key Management of Cencora Inc.

Name

Title

Ms. Elizabeth S. Campbell J.D.

Executive VP & Chief Legal Officer

Ms. Silvana Battaglia

Executive VP & Chief Human Resources Officer

Mr. Lazarus Krikorian

Senior VP, Chief Accounting Officer & Corporate Controller

Mr. Pawan Singh Verma

Executive VP and Chief Data & Information Officer

Mr. François Mandeville

Executive VP and Chief Strategy and M&A Officer

Dr. Robert P. Mauch Ph.D., PharmD

President, CEO & Director

Mr. James F. Cleary Jr.

Executive VP & CFO

Mr. Bennett S. Murphy

Senior VP Of Investor Relations & Enterprise Productivity and Treasury

Mr. Richard Tremonte

EVP and President of U.S. Pharmaceuticals & Animal Health

Mr. Juan Guerra

EVP & President of International Business Group

FAQs

What is Cencora Inc. share price today?

Cencora Inc. share price today is $327.54 as on at the close of the market. Cencora Inc. share today touched a day high of $323.66 and a low of $317.65.

What is the 52 week high and 52 week low for Cencora Inc. share?

Cencora Inc. share touched a 52 week high of $377.54 on and a 52 week low of $271 on . Cencora Inc. stock price today i.e. is closed at $327.54,which is 13.24% down from its 52 week high and 20.86% up from its 52 week low.

What is Cencora Inc.'s market capitalisation today?

Cencora Inc. market capitalisation is $0.06T as on .

How to invest in Cencora Inc. Stock (COR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cencora Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cencora Inc. Shares that will get you 0.0046 shares as per Cencora Inc. share price of $327.54 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cencora Inc. Stock (COR) from India?

Indian investors can start investing in Cencora Inc. (COR) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Cencora Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Cencora Inc. share’s latest price of $327.54 as on April 18, 2026 at 1:29 am IST, you will get 0.0305 shares of Cencora Inc.. Learn more about fractional shares .

What are the returns that Cencora Inc. has given to Indian investors in the last 5 years?

Cencora Inc. stock has given 163.44% share price returns and 24.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?